chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Pt developed erythematous macular rash across torso approx 1-1.5wks after the 2nd dose of vaccination; This is a spontaneous report from a contactable physician. A 37-years-old non-pregnant female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN), dose 2 intramuscular, administered in Arm Left on 30Apr2021 (at the age of 37-years-old) as a single dose for covid-19 immunization. Patient previously received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN), dose 1 via an unspecified route of administration on 09Apr2021 (at the age of 37-years-old) as a single dose for covid-19 immunization. Medical history included hypothyroidism, depression, hyperlipidemia. Concomitant medication(s) and received within 2 weeks of vaccination included atorvastatin, SYNTHROID, PAXIL, ORTHO TRI-CYCLEN. The patient had allergies with metaclazepam drug hypersensitivity. The patient had no other vaccine within four weeks. On 10May2021, the patient experienced erythematous macular rash across torso approximately 1-1.5wks after the 2nd dose of vaccination. The adverse event resulted in doctor or other healthcare professional office/clinic visit. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had been tested for COVID-19. The patient underwent lab tests and procedures which included nasal swab, sars-cov-2 test negative on May2021. The patient received treatment for the adverse event with betamethasone cream topically. Outcome of the event was not recovered. Device Date was 19May2021. Information regarding the lot/batch number has been requested. No new information was received.
Symptoms-  Chest Pain, Headaches,  high blood pressure ,  Myalgia
fever; chills; muscle aches; This case was reported by a consumer via call center representative and described the occurrence of fever in a 71-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   On 12th September 2019, the patient received the 1st dose of Shingrix. On 13th September 2019, 1 days after receiving Shingrix, the patient experienced fever (serious criteria hospitalization), chills (serious criteria hospitalization) and muscle pain (serious criteria hospitalization). On 16th September 2019, the outcome of the fever, chills and muscle pain were recovered/resolved.   It was unknown if the reporter considered the fever, chills and muscle pain to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported. The patient received Shingrix in left arm. The patient received Shingrix and following day, she woke up with fever, chills and muscle aches. On 14th September 2019, the patient's fever rose to 103.2 degrees F, so prompted an emergency room visit (ER) and the patient was admitted that day and stayed three days. On 17th September 2019, the patient was discharged with all symptoms resolved. The reporter consented to follow up.
This spontaneous report was received from a physician via company representatives and refers to a patient of unknown age and gender. The patient's medical history, concurrent conditions or concomitant therapies were not reported. On 14-OCT-2014, the patient was vaccinated with a 0.5 ml dose of PNEUMOVAX 23 "10 Single DS 0.5 ml LVls 10SDV", lot # K004148, expiration date 10-MAY-2015 (route was not reported). This vaccine was improperly stored exposed to two temperature excursions for a sum of 72 hours at a highest temperature recorded of 47 degrees F (8.333333333 degrees C), and the other for a sum of 72 hours at a lowest temperature recorded of 34 degrees F (1.111111111 degrees C). The vaccine status was reported as "in excursion". The vaccine storage criteria and type were reported as "refrigerator (R)". No adverse effects were reported. There was no product quality complained involved. This is one of several reports received from the same reporter. Additional information has been requested.
patient fainted less than a minute after injection. She regained consciousness and were taking care by fire department crews . Other wise doing fine.
Child had flu shot @ about 10 am. Waited in office for 20 minutes. Went home w/mother and private duty nurse. Nurse reported he was fussy after the immunization. She held him until he went to sleep. They put child to bed in parental bedroom upstairs. Nurse went to kitchen to get g-tube feeds ready. Apnea alarm went off shortly thereafter. When RN got to the child, he was face down in the bed and blue. They administered CPR, called 911. He was airlifted to hospital, where he was pronounced dead approximately two hours after receiving the flu shot.  11/13/07 Received autopsy report which reveals COD as complications of cerebral dysgenesis of indeterminate etiology; arthrogryposis multiplex congenita was a significant contributing factor.  Had been placed on side for nap but was found prone.  Disabilities rendered unable to lift head/body to protect airway. 11/16/07 Received vax records from pcp.  VAERS database updated w/same.
Information has been received from a health professional concerning a 48 year old female with a recent diagnosis of diabetes who on 25-OCT-2006 was vaccinated subcutaneously in the left upper arm with a dose of Pneumovax 23 (lot #651401/0619F). On 26-OCT-2006 the patient's left upper arm developed an area of large erythematous induration and was tender and warm to touch, consistent with cellulitis and urticaria. On 27-OCT-2006, the patient was seen and treated with AUGMENTIN 875 mg twice a day for 10 days. No laboratory diagnostic studies were performed. On 01-NOV-2006, the patient recovered. No product quality complaint was involved. Additional information is not expected.
Rapid heart beat varying from 103-120 beats per minute on 3/7/21, the date after vacination
After receiving my Moderna Booster vaccine on January 4, 2022, my entire left arm, hand, underarm, shoulder, back of shoulder, is very painful w some inflamation in my lymph nodes of arm pit. The pain radiates down my arm and across to other shoulder at times.
Horrible body odor; Extreme night sweats; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team, Program ID: (RA).  A female patient received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), as dose number unknown (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Covid-19 vaccine (Primary Immunization series complete; unknown manufacturer), for COVID-19 immunization. The following information was reported: SKIN ODOUR ABNORMAL (non-serious), outcome "unknown", described as "Horrible body odor"; NIGHT SWEATS (non-serious), outcome "unknown", described as "Extreme night sweats".  Additional information: The reporter wanted to know whether we had any information on how to get rid of the horrible body odor as a side effect of the booster shots. The reporter so far known 12 women with this issue. They also had extreme night sweats. The reporter had read 12 different articles regarding this side effect. A lot of people were having this trouble and this was becoming a major problem.   The information on the batch/lot number for BNT162b2, BNT162b2 omi ba.4-5 has been requested and will be submitted if and when received.
Immunization given. Patient td well. To waiting room. Approx 5 min later patient jerking. Noticed by mother. Lasted approx 10-15 sec. Nurse went to patient. Patient awoke not sure of where she was. Patient c/o vertigo. Vomited. Assisted to exam room B/P 92/60 P62 R16 recovered. Patient resting on bed. Does not recall injection or what. Observed patient for 60 min. Patient c/o feeling fine. B/P 90/60 P62. Home with mother in good condition.
First injection in left arm, Head ache lasting for 4 Days, arm sore for 5 Days.  Second injection  after an hour tingling in left side of lip and pain in the left jaw joint.  Head ache still persistant.  Tingling went away after 6 HR and pain in jaw joint stopped.
GOT PARTIAL DOSE; This spontaneous report received from a consumer concerned a male of unspecified age. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: G200707 expiry: UNKNOWN) dose was not reported, administered on 10-MAR-2021 at around 15:35 for prophylactic vaccination. No concomitant medications were reported. On 10-MAR-2021 at around 15:35, the subject experienced got partial dose. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of got partial dose was not reported. This report was non-serious.
Cardiac arrest with CPR/cardioversion and ICU care for 5 days. Discharge Summary received on 1/12/2005 states pt experienced ventricular fibrillation and was unresponsive.
Client verbalized feeling mild shortness of breath after receiving the vaccine.  Full assessment done by on-site Paramedics.  After symptom was resolved client was cleared to go home at 9:56 am.
After the first shot she experienced a changed in her menstrual cycle, So it was longer and heavy than normal; After the first shot she experienced a changed in her menstrual cycle, So it was longer and heavy than normal; This is a spontaneous report from a contactable consumer (patient) reported for herself. A 35-years-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot number: FC3180, Expiration date: unknown) via an unspecified route of administration, administered in left arm on 23Aug2021 at 15:00 pm (age at vaccination was 35 years) as dose 1, single for COVID-19 immunization. The patient did not have any medical history. The patient's concomitant medications were not reported. The facility where the first COVID-19 vaccine was administered was Pharmacy. The vaccine was not administered at Facility. There was no history of any previous immunization with the Pfizer vaccine considered as suspect. No additional vaccines were administered on same date of the Pfizer suspect. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 28Aug2021, after the first shot the patient experienced a change in her menstrual cycle. Her normal period was 4-5 days and starts low with a small amount in the first day, then on the 2nd-3rd days was heavy, then the last days was just a small portion of blood. She was also very regular, it comes every 27-28 days. This time, after the first vaccine it came early. Then it was 1.5 days with no blood. After that, it came really strong and heavy, lasting for another 6 days. So it was longer and heavy than normal, from the first signs of blood it was 9 days total instead of the 4-5 days it normally lasts. She marked her calendar as it starting on 30Aug2021 but it was the 28Aug2021 when she had the first sign and nothing until the 30Aug2021. The caller noted she didn't have accidents anymore, she was too regular. This time there was no sign and she was surprised. The caller asked if that happens after the second dose should she call back. The adverse events did not require a visit to Emergency room or Physician office. No relevant tests were done. The patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot number: EW0177, Expiration date: unknown) via an unspecified route of administration, administered in left arm on an unspecified date in Sep2021 at around 10:30 to 11:00 am (age at vaccination was 35 years) as dose 2, single for COVID-19 immunization. After the second dose of vaccine, the patient noted that she felt sick and she couldn't even talk right, she woke up feeling that way. The outcome of the events was unknown.
Sore; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE PAIN (Sore) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030L20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No medical history provided.). Concomitant products included LEVOTHYROXINE.    On 21-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 21-Jan-2021, the patient experienced INJECTION SITE PAIN (Sore). At the time of the report, INJECTION SITE PAIN (Sore) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Body aches in left shoulder, overnight nausea.  These adverse reactions are not so concerning because I have heard how commonly these are experienced. What is most concerning is that I woke up at 3:30 AM feeling nauseous and made my way to the bathroom as a result. At some point, once entering the bathroom, I lost consciousness and when regaining consciousness saw that I had pulled the entire toilet off the floor, cracking the large reservoir and breaking the lid into several pieces. Water was spraying and leaking. Fortunately, I did not suffer a bruise or cut. I am, however, concerned whether I should expect to lose consciousness again.
Had shingles vaccine and got the shingle/ suspected vaccination failure; Had shingles twice in back one in left side and one on right upper chest neck area; Nerve pain in back area; Itch is crazy; Area gets so hot; This serious case was reported by a consumer via interactive digital media and described the occurrence of vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, an unknown time after receiving Shingles vaccine, the patient experienced vaccination failure (Verbatim: Had shingles vaccine and got the shingle/ suspected vaccination failure) (serious criteria GSK medically significant), shingles (Verbatim: Had shingles twice in back one in left side and one on right upper chest neck area), post herpetic neuralgia (Verbatim: Nerve pain in back area), pruritus (Verbatim: Itch is crazy) and skin warm (Verbatim: Area gets so hot). The outcome of the vaccination failure was unknown and the outcome of the shingles, pruritus and skin warm were not reported and the outcome of the post herpetic neuralgia was not resolved.   It was unknown if the reporter considered the vaccination failure, shingles, post herpetic neuralgia, pruritus and skin warm to be related to Shingles vaccine.     It was unknown if the company considered the vaccination failure, shingles, post herpetic neuralgia, pruritus and skin warm to be related to Shingles vaccine.   Additional Information: GSK Receipt Date: 19-MAR-2023 This case was reported by a patient via interactive digital media. The patient reported that he or she received Shingles vaccine and experienced shingles it was crazy itchy and that area got so hot. The patient stated that he or she still get nerve pain in his or her back area where he or she had shingles and the back area was his or her was worst. This case was considered as suspected vaccination failure as details regarding completion of primary schedule, time to onset for shingles and laboratory confirmation regarding shingles were unknown at the time of reporting. Follow-up would not possible as no contact details were available.
had a dull achy sore pain where the shot was administered ever since I received the last shot; tingliess in my fingers on that arm; This is a spontaneous report from a contactable consumer or other non hcp (patient). A 31-years-old non-pregnant female patient received second dose of BNT162B2 (Pfizer-Biontech Covid-19 Vaccine, Formulation: solution for injection, Batch/Lot Number unspecified, expiration date unspecified), via an unspecified route of administration, administered in Arm Left on 18Mar2021 11:00 as 2ND DOSE, SINGLE DOSE for covid-19 immunisation at pharmacy or drug store. Previously the patient had BNT162B2 (Pfizer-Biontech Covid-19 Vaccine, Formulation: solution for injection, Batch/Lot Number unspecified, expiration date unspecified) via unspecified route of administration on 25Feb2021 12:15PM, as 1ST DOSE, SINGLE DOSE for covid-19 immunization. The patient did not receive any vaccination prior 4weeks of the vaccination. Medical history included anxiety. The patient's concomitant medications were not reported. On the same day, post vaccination the patient had a dull achy sore pain where the shot was administered ever since she received the last shot. The patient also had tingliess in fingers on that arm. The patient was treated with Zoloft 100mg and Vistaril 100mg at an unknown dose. The outcome of the events was reported as not recovered at the time of report.  Information on the lot/batch number has been requested.
His wife experienced a slighty sore swollen arm with first vaccine; His wife experienced a slighty sore swollen arm with first vaccine; This spontaneous case was reported by a patient family member or friend and describes the occurrence of PAIN IN EXTREMITY (His wife experienced a slighty sore swollen arm with first vaccine) and PERIPHERAL SWELLING (His wife experienced a slighty sore swollen arm with first vaccine) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included Shingles. Concurrent medical conditions included Bell's palsy.    On 22-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (His wife experienced a slighty sore swollen arm with first vaccine) and PERIPHERAL SWELLING (His wife experienced a slighty sore swollen arm with first vaccine). At the time of the report, PAIN IN EXTREMITY (His wife experienced a slighty sore swollen arm with first vaccine) and PERIPHERAL SWELLING (His wife experienced a slighty sore swollen arm with first vaccine) outcome was unknown.        mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosing remained unchanged.       No concomitant medications were reported. No treatment medications were reported.   This case was linked to MOD-2021-337846 (Patient Link).
Fever 102.2, chills, extreme body aches, stomach cramps, headache with light sensitivity.
Positive Covid test 7/10/2022, fever, slight cough, headache, lasted for 3 days. Breakthrough Covid. Paxlovid 150 (X2) -100 mg PK (EUA) for 5 days. Negative Covid tests 7/16/2022 and 7/18/2022. Symptoms returned, positive Covid test 7/23/2022. Rebound Covid, increased cough, congestion, shortness of breath, with mild fever.
pt recvd vax 6FEB95 & by late afternoon pt was listless & sleepy;by 708PM had t103;BY 9-10PM had 105+ fever, extremely listless & unresponsive;given APAP & lukewarm bath, temp down to 101;sleepy next 2 days then recovered;
Donor received a tetanus injection on 4-29-08, he stated he developed pain and a hard nodule in the same arm appx 4 days later then he developed a blotchy rash down both arms and across his chest.  No itching or irritation noted.
Within 1 hour of injection, patient reported 'tingling' feeling and loss of sensation down injection arm. She stated it was intermittent and felt like something was 'crawling' on her skin. She said she had never felt this from previous vaccinations. She reported no loss of grip, muscle weakness, or pain. Stated is extended from the injection site down to her hand. She had mentioned there were longer time intervals between the 'tingly' sensation since she first noticed it, but it hadn't stopped yet.
Severe headache, from back of head to front forehead. Lasting two weeks exactly. Two grand-mal seizures on day 13. Unknown if seizures were related.
Itching, redness and swelling from injection site down to the elbow area. Also swelling under the arm to the left side of the left breast with tenderness upon pressing on the left breast.  Skin is very tender to touch when I try to scratch it. There is a pink tint to the skin but not red. Am not running a fever.
This child had Varicella in mouth and on body. No vaccine listed . States vaccine was given at another facility.
Vaccinator was unable to obtain a wheal with the first attempt at vaccination.  On the 2nd attempt vaccinator obtained a wheal.  Second attempt was 2 inches away from the 1st stick on the same arm.
Got my pneumonia shot at 9:00 am. My arm was stiff by 2:30 PM and severe pain in arm. Got very cold all over till 10:00 pm. Threw up at 10:30 pm. Called hospital about 10:30 pm and asked if I should came in. They connected me with dr who said the ER couldn't do anything for me. My arm has had bad pain now for six days but I can move it more now. It was stiff at my side for two to three days. Around 10:00 am on 10-21-13, I went to hosp and got a flu shot. That arm never got sore. P.S. Today is 10-27-13 and my arm is still some what stiff and painful.
Information has been received from a physician concerning a 60 year old male patient who on 23MAY-2008 was vaccinated with first dose of ZOSTAVAX (LOT # 659763/1875U), intramuscularly at 10:00 hours. There was no concomitant medication. The physician reported that on 04-JUN-2008, the patient developed paresthesian patch like, at the left anterior cervical region with skin eruption. it appeared patient developed zoster 15 days post vaccination. The patient's symptoms (unspecified symptoms) started 3 days before, in approximately 04-JUN-2008. The patient was given VALTREX. At the time of the report the patient was recovering. The patient sought medical attention. Diagnostic test was clinical exam only. No further information in available.
Patient called and stated that she received her vaccine 2/8/21. She reports that night she went to sleep and woke up around 9:00PM with her heart racing. When she checked it her heart rate was 122. She states that it resolved within about 2 hours. She said the same thing happened the next night. She reports having multiple episodes of feeling like her heart is racing and beating out of her chest.
Mom noticed several small 2 cm white raised bumps appearing on patient's arms and back within 2 hours of vaccine administration. These white bumps quickly developed into larger red pruritic bumps which spread over patient's scalp, neck, trunk, arms, and legs. Within 15 mins, parents drove patient back to pediatrician's office for evaluation. In the car, he began to exhibit signs of respiratory distress - he was taking swallow breaths, had audible upper airway sounds (not stridor or wheezing, but sounded like an adult when they're handling post-nasal drip), and looked very uncomfortable. Did not shows signs of tongue swelling, complete airway obstruction, apnea, or cyanosis. His lips were swollen in the area where there were hives. Upon arrival at the pediatrician's office, patient was given Benadryl, which quickly alleviated his respiratory symptoms and skin findings.